Healthcare -
Biotechnology - NASDAQ - US
$ 13.78
3.07 %
$ 516 M
Market Cap
9.57
P/E
TRDA - CAPITAL EXPENDITURES
Capital Expenditures TRDA - Entrada Therapeutics, Inc.
-5.61 M
LAST VALUE
-10.71%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR